What dose of sertraline is equivalent to 25 mg of escitalopram (Lexapro)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sertraline Dose Equivalent to Escitalopram 25mg

The equivalent dose of sertraline to escitalopram 25 mg is approximately 125 mg/day, based on the most rigorous dose-equivalence methodology available.

Evidence-Based Dose Conversion

The most reliable data comes from a systematic analysis of randomized controlled trials that calculated weighted mean dose ratios across multiple studies 1. Using fluoxetine 40 mg/day as the reference standard:

  • Escitalopram equivalent: 18.0 mg/day
  • Sertraline equivalent: 98.5 mg/day

This yields a sertraline-to-escitalopram ratio of approximately 5.5:1. Therefore:

  • Escitalopram 25 mg ÷ 18 mg × 98.5 mg sertraline = approximately 137 mg sertraline
  • Using the direct ratio: 25 mg × 5.5 = 137.5 mg sertraline

In clinical practice, this translates to sertraline 125-150 mg/day as equivalent to escitalopram 25 mg/day.

Practical Dosing Considerations

Starting and Titration Strategy

When switching from escitalopram 25 mg to sertraline:

  1. Initial dose: Start sertraline at 50 mg/day (standard FDA-approved starting dose for depression) 22
  2. Titration: Increase by 50 mg increments weekly as tolerated
  3. Target dose: Aim for 125-150 mg/day to achieve equivalent therapeutic effect
  4. Maximum: Up to 200 mg/day if needed for optimal response 2

Important Caveats

Pharmacokinetic differences matter: While dose equivalence provides a starting framework, escitalopram and sertraline differ in several clinically relevant ways:

  • Half-life: Sertraline has a 24-hour elimination half-life, requiring dose changes at minimum 1-week intervals 2
  • CYP2C19 metabolism: Both drugs are metabolized by CYP2C19, but the impact is more pronounced for escitalopram than sertraline 3. Poor metabolizers may require lower doses, while ultrarapid metabolizers may need higher doses or twice-daily dosing
  • Drug interactions: Sertraline has less effect on cytochrome P450 metabolism compared to other SSRIs, potentially offering fewer drug-drug interactions 45

Clinical equivalence vs. dose equivalence: A head-to-head trial found that escitalopram 10 mg/day showed comparable efficacy to sertraline flexibly dosed at 50-200 mg/day (mean 144 mg/day) 6. This supports the 5:1 to 7:1 ratio range for clinical equivalence.

Safety Profile Differences

Both medications are generally well-tolerated, but note:

  • Discontinuation syndrome: Sertraline carries risk of withdrawal symptoms with abrupt discontinuation 55; taper over 10-14 days when stopping 4
  • QT prolongation: Recent data suggest sertraline may have modestly lower QTc-specific event risk compared to escitalopram/citalopram 7, though the clinical significance is small
  • Adverse effects: Both have similar side effect profiles (nausea, dry mouth, sexual dysfunction, activation) 85

Monitoring After Conversion

  • Assess response at 1 week (early symptom changes may differ between agents) 9
  • Full therapeutic assessment at 4-8 weeks on target dose 2
  • Monitor for activation, suicidality (especially in patients <25 years), and discontinuation symptoms if switching directly 85

Bottom line: Use sertraline 125-150 mg/day as the practical equivalent to escitalopram 25 mg/day, with individual titration based on response and tolerability over 2-4 weeks.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.